logo
Plus   Neg
Share
Email

Surmodics Issues FY19 Outlook - Quick Facts

Surmodics, Inc. (SRDX) announced, for fiscal year 2019, the company expects non-GAAP result per share to be between a loss of $0.07 and profit of $0.23 per share. Revenue is expected to to range from $92 million to $97 million.

On a non-GAAP basis, earnings per share were $0.05 in the fourth quarter, as compared with $0.18 in the year-ago period. Total revenue was $23.0 million, as compared with $20.1 million in the prior-year period. Medical Device revenue was $17.0 million in the fourth quarter, compared with $14.7 million in the year-ago period, an increase of 15.4%, and included $2.2 million from SurVeil agreement with Abbott.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While reporting financial results for the first quarter, American Express Co. (AXP) on Thursday affirmed its earnings and revenue growth guidance for the full-year 2019. For fiscal 2019, the company continues to project earnings in the range of $7.64 to $8.14 per share and adjusted earnings in the... While reporting financial results for the first quarter, Honeywell international Inc. (HON) on Thursday raised its earnings and sales outlook for the full-year 2019. For fiscal 2019, the company raised its earnings outlook to a range of $7.90 to $8.15 per share from the previous guidance range of... Chipmaker Intel Corp. said it plans to exit the 5G smartphone modem business, with the announcement coming just hours after Apple Inc. and Qualcomm Inc. said they have settled their royalty dispute. The settlement includes a payment from Apple to Qualcomm, but no details were disclosed about the payment or fees. Qualcomm's shares are gaining more than 14 percent in Wednesday's trading session.
Follow RTT